Dr. Sol Cabrera
Dr. Bart Sanders
During the Dutch Life Sciences conference in Leiden, the founders of STENTiT pitched their business plan to a group of life science investors. Among the candidates, STENTiT was unanimously chosen by the jury as the winner of the Investors Forum. In addition, STENTiT presented the case in front of a large audience during the plenary[…]
The NanoNextNL valorization committee has approved to provide financial support to develop the STENTiT business case. NanoNextNL is the Dutch national research and technology programme for micro and nano technology.
The Venture Challenge is an initiative from LifeSciences@Work, designed for life science researchers with entrepreneurial aspirations. STENTiT was selected as one of the 5 participants after pitching the business case to an experienced jury panel. The aim of the program is to develop an idea into a solid business case during a 10-week educational program[…]
The Metropolitan Region Eindhoven provided financial support to STENTiT in the shape of the “Stimuleringsfonds” subsidy. This funding will enable a close collaboration with regional clinical and industrial partners, to further improve the regenerative stent technology. The goal of the subsidy is to support bright ideas by giving them the financial opportunity to enhance their[…]
STENTiT presented the preliminary results of their regenerative stent technology last Monday by Sol Cabrera and Bart Sanders, during the 10th anniversary Biomedica Summit event in Germany. The jury acknowledged the innovative approach and awarded a cash price for being the best poster presentation in the category Medtech/Care. With around 70 large and small exhibitors[…]
STENTiT obtained the first pre-seed grant from the STW Take-Off program. The goal is to initiate the development of a new type of biodegradable stent for pediatric applications. The Take-Off Grant helps academic entrepreneurs with their spin-off company to make the step from an idea to a first prototype. The Take-Off instrument includes two stages;[…]